Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Shaney L. Barratt"'
Autor:
Giles Dixon, Samuel Hague, Sarah Mulholland, Huzaifa Adamali, Aye Myat Noe Khin, Hannah Thould, Roisin Connon, Paul Minnis, Eoin Murtagh, Fasihul Khan, Sameen Toor, Alexandra Lawrence, Marium Naqvi, Alex West, Robina K. Coker, Katie Ward, Leda Yazbeck, Simon Hart, Theresa Garfoot, Kate Newman, Pilar Rivera-Ortega, Lachlan Stranks, Paul Beirne, Jessica Bradley, Catherine Rowan, Sarah Agnew, Mahin Ahmad, Lisa G. Spencer, Joshua Aigbirior, Ahmed Fahim, Andrew M. Wilson, Elizabeth Butcher, Sy Giin Chong, Gauri Saini, Sabrina Zulfikar, Felix Chua, Peter M. George, Maria Kokosi, Vasileios Kouranos, Philip Molyneaux, Elisabetta Renzoni, Benedetta Vitri, Athol U. Wells, Lisa M. Nicol, Stephen Bianchi, Raman Kular, HuaJian Liu, Alexander John, Sarah Barth, Melissa Wickremasinghe, Ian A. Forrest, Ian Grimes, A. John Simpson, Sophie V. Fletcher, Mark G. Jones, Emma Kinsella, Jennifer Naftel, Nicola Wood, Jodie Chalmers, Anjali Crawshaw, Louise E. Crowley, Davinder Dosanjh, Christopher C. Huntley, Gareth I. Walters, Timothy Gatheral, Catherine Plum, Shiva Bikmalla, Raja Muthusami, Helen Stone, Jonathan C.L. Rodrigues, Krasimira Tsaneva-Atanasova, Chris J. Scotton, Michael A. Gibbons, Shaney L. Barratt
Publikováno v:
ERJ Open Research, Vol 10, Iss 1 (2024)
Background Nintedanib slows progression of lung function decline in patients with progressive fibrosing (PF) interstitial lung disease (ILD) and was recommended for this indication within the United Kingdom (UK) National Health Service in Scotland in
Externí odkaz:
https://doaj.org/article/de9c81f7baad42d39a03dbc60d9a1955
Autor:
Oluwabukola Thomas-Orogan, Shaney L. Barratt, Muhammad Zafran, Apollo Kwok, Anneliese Simons, Eoin P. Judge, Matthew Wells, Richard Daly, Charles Sharp, Abiramy Jeyabalan, Martin Plummeridge, Ladli Chandratreya, Lisa G. Spencer, Andrew R. L. Medford, Huzaifa I. Adamali
Publikováno v:
Diagnostics, Vol 14, Iss 3, p 237 (2024)
Introduction: Sarcoidosis is a multi-system granulomatous disease most commonly involving the lungs. It may be incidentally diagnosed during imaging studies for other conditions or non-specific symptoms. The appropriate follow-up of incidentally diag
Externí odkaz:
https://doaj.org/article/84fef033c7244cfd8da0f433c0829cd0
Autor:
Lavanya Raman, Iain Stewart, Shaney L. Barratt, Felix Chua, Nazia Chaudhuri, Anjali Crawshaw, Michael Gibbons, Charlotte Hogben, Rachel Hoyles, Vasilis Kouranos, Jennifer Martinovic, Sarah Mulholland, Katherine J. Myall, Marium Naqvi, Elisabetta A. Renzoni, Peter Saunders, Matthew Steward, Dharmic Suresh, Muhunthan Thillai, Athol U. Wells, Alex West, Jane A. Mitchell, Peter M. George
Publikováno v:
ERJ Open Research, Vol 9, Iss 2 (2023)
Background Nintedanib slows lung function decline for patients with non-idiopathic pulmonary fibrosis progressive pulmonary fibrosis (PPF) in clinical trials, but the real-world safety and efficacy are not known. Methods In this retrospective cohort
Externí odkaz:
https://doaj.org/article/9530ec38c0ad4a02b0170487e8522d7a
Autor:
Theresia A. Mikolasch, Peter M. George, Jagdeep Sahota, Thomas Nancarrow, Shaney L. Barratt, Felix A. Woodhead, Vasilis Kouranos, Victoria S.A. Cope, Andrew W. Creamer, Silan Fidan, Balaji Ganeshan, Luke Hoy, John A. Mackintosh, Robert Shortman, Anna Duckworth, Janet Fallon, Helen Garthwaite, Melissa Heightman, Huzaifa I. Adamali, Sarah Lines, Thida Win, Rebecca Wollerton, Elisabetta A. Renzoni, Matthew Steward, Athol U. Wells, Michael Gibbons, Ashley M. Groves, Bibek Gooptu, Chris J. Scotton, Joanna C. Porter
Publikováno v:
EClinicalMedicine, Vol 55, Iss , Pp 101758- (2023)
Summary: Background: Idiopathic pulmonary fibrosis (IPF) is a progressive, fatal disorder with a variable disease trajectory. The aim of this study was to assess the potential of neutrophil-to-lymphocyte ratio (NLR) to predict outcomes in IPF. Method
Externí odkaz:
https://doaj.org/article/85fa843c585542cbaba15e6d4040db5d
Autor:
Matthew Wells, Sughra Alawi, Kyaing Yi Mon Thin, Harsha Gunawardena, Adrian R. Brown, Anthony Edey, John D. Pauling, Shaney L. Barratt, Huzaifa I. Adamali
Publikováno v:
Frontiers in Medicine, Vol 9 (2022)
Antisynthetase syndrome is a subtype of idiopathic inflammatory myopathy, strongly associated with the presence of interstitial lung disease. Diagnosis is made by identifying myositis-specific antibodies directed against aminoacyl tRNA synthetase, an
Externí odkaz:
https://doaj.org/article/810a4f61c02041a1a73c2e8e7467d44e
Autor:
Andrew W. Creamer, Shaney L. Barratt
Publikováno v:
Breathe, Vol 15, Iss 2, Pp 140-143 (2019)
Externí odkaz:
https://doaj.org/article/db4509fba1f34a69af53b47b903e7421
Publikováno v:
ERJ Open Research, Vol 6, Iss 3 (2020)
The heterogeneity of interstitial lung disease (ILD) results in prognostic uncertainty concerning end-of-life discussions and optimal timing for transplantation. Effective prognostic markers and prediction models are needed. Cardiopulmonary exercise
Externí odkaz:
https://doaj.org/article/986393b1f05b47baaab4fbc41d63d546
Autor:
Andrew W. Creamer, Shaney L. Barratt
Publikováno v:
European Respiratory Review, Vol 29, Iss 156 (2020)
Hypersensitivity pneumonitis (HP) is an immunologically mediated lung disease resulting from exposure to inhaled environmental antigens. Prognosis is variable, with a subset of patients developing progressive fibrosis leading to respiratory failure a
Externí odkaz:
https://doaj.org/article/22ce7ada5f0748ff991bf4b6300f22cb
Autor:
Shaney L. Barratt, Thomas Blythe, Khadija Ourradi, Caroline Jarrett, Gavin I. Welsh, David O. Bates, Ann B. Millar
Publikováno v:
Respiratory Research, Vol 19, Iss 1, Pp 1-5 (2018)
Abstract Dysregulation of VEGF-A bioavailability has been implicated in the development of lung injury/fibrosis, exemplified by Idiopathic Pulmonary Fibrosis (IPF). VEGF-A is a target of the hypoxic response via its translational regulation by HIF-1
Externí odkaz:
https://doaj.org/article/120bb84e425d477797fb1bb9fb2175c7
Autor:
Sarah Younus, Jeffrey A. Bakal, Janice Richman-Eisenstat, Ghadah Alrehaili, Sharina Aldhaheri, Michelle Morales, Naomi Rippon, Elisabeth Bendstrup, Ingrid Harle, Onofre Moran-Mendoza, Shaney L. Barratt, Huzaifa Adamali, Meena Kalluri
Publikováno v:
Applied Sciences, Vol 11, Iss 19, p 9028 (2021)
Introduction: Palliative care (PC) is recommended in idiopathic pulmonary fibrosis (IPF) patients but poorly implemented. Integration of PC into routine management by pulmonologists may improve overall and end-of-life (EOL) care, but the optimal mode
Externí odkaz:
https://doaj.org/article/9fb24fd6903d4325bb5afca3d79a430b